STING agonist

Ph. II candidate for met. H&N cancer

from SBDD of endogenous ligand

Clin. Cancer Res.

Aduro (Chinook Therapeutics)

STING agonist - Aduro (Chinook Therapeutics)

MIW815 (ADU-S100) is a first-in-class STING agonist for cancer immunotherapy. Agonism of the STING (stimulator of IFN genes) receptor, true to its name, leads to stimulation of type I…


get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: